Science Explorer Back to mapMap
Discussion
Researcher · Seoul National University Bundang Hospital · South Korea

Soo Lim

Soo Lim publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, on topics such as Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins and Metabolism, Diabetes, and Cancer.

ORCID 0000-0002-4137-1671 OpenAlex
World rank
#112,955
of 7,710,434 ranked researchers
Rank in South Korea
#547
of 162,609
Works
515
Citations
21k
Citations per work
40.4
h-index
70
i10-index 304Top 1.1% in Endocrinology, Diabetes and Metabolism
Soo Lim

What does Soo Lim research?

Soo Lim's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 278 works · 54.0% of their workMedicine: 278 works · 54.0% of their workEndocrinology, Diabetes and Metabolism: 124 works · 24.0% of their workSurgery: 47 works · 9.2% of their workPhysiology: 44 works · 8.6% of their workCardiology and Cardiovascular Medicine: 38 works · 7.4% of their workEpidemiology: 25 works · 4.8% of their workEverything else: 190 works · 36.9% of their workLife Sciences: 47 works · 9.1% of their workBiochemistry, Genetics and Molecular Biology: 47 works · 9.1% of their workMolecular Biology: 47 works · 9.1% of their workTHEIR WORKSoo Lim515works
Life Sciences9%Health Sciences54%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine27854.0%
  2. Everything else19036.9%
    1. Biochemistry, Genetics and Molecular Biology479.1%
  1. 1Endocrinology, Diabetes and Metabolism24% of their works
  2. 2Surgery9% of their works
  3. 3Molecular Biology9% of their works
  4. 4Physiology9% of their works
  5. 5Cardiology and Cardiovascular Medicine7% of their works
  6. 6Epidemiology5% of their works

Research topics

Which keywords describe Soo Lim's research?

The keywords of their largest research topics: Cardiovascular Disease, Glycemic Control, Insulin Therapy, Obesity, Type 2 Diabetes, Diabetes, Insulin Resistance and Metabolic Syndrome.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cardiovascular Disease1653 topics
  2. Glycemic Control1542 topics
  3. Insulin Therapy1542 topics
  4. Obesity1533 topics
  5. Type 2 Diabetes1512 topics
  6. Diabetes1262 topics
  7. Insulin Resistance1232 topics
  8. Metabolic Syndrome1232 topics
  9. Cardiovascular Outcomes1121 topic
  10. Glucose Control1121 topic
  11. Atherosclerosis841 topic
  12. Glucose Metabolism841 topic
  13. Inflammation822 topics
  14. Muscle Mass732 topics
  15. AMP-Activated Protein Kinase471 topic
  16. Metformin471 topic
  17. Cancer Cachexia431 topic
  18. Sarcopenia431 topic
  19. Continuous Glucose Monitoring421 topic
  20. Hypoglycemia421 topic
  21. Adipokines391 topic
  22. Adipose Tissue391 topic
  23. Pancreatic Islets381 topic
  24. ß-Cell Dysfunction381 topic
  25. Bioelectrical Impedance Analysis301 topic
  26. Body Mass Index301 topic

Where does Soo Lim work?

Soo Lim's main affiliation in the publication record is Seoul National University Bundang Hospital, South Korea.

How many publications and citations does Soo Lim have?

OpenAlex counts 515 works and 20,788 citations for Soo Lim, an h-index of 70, ranking #112,955 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Soo Lim. Posts are plain text and can be reported.